Propofol: A Safer Future Forged from a Lethal Past

Abstract

In modern medicine, few pharmacological agents have been as transformative as propofol. Widely regarded as the gold standard for intravenous induction and maintenance of anaesthesia, it has reshaped perioperative care worldwide. Yet, behind its clinical use lies a lesser-known narrative: one shaped by the limitations of thiopentone, the tragedies of wartime medicine, and the pivotal role of Irish research in ensuring propofol’s safe implementation.

Before propofol’s introduction in the 1980’s, anaesthetists relied heavily on thiopentone sodium, a barbiturate first synthesised in the 1930’s. Although revolutionary for its rapid onset, thiopentone’s pharmacology proved problematic. It is a haemodynamic depressant and cannot be used to maintain anaesthesia. After injection, thiopentone redistributes into highly perfused tissues (e.g., muscle) and once administration ceases, it diffuses back into the circulation, leading to prolonged drowsiness and unpredictable patient responses. This renders it impractical as a sole anaesthetic agent. During World War II, thiopentone, thought to be an ideal field anaesthetic, was used on American soldiers at Pearl Harbour. Tragically, many who might otherwise have survived, succumbed to its cardiac depressant effects.